Kidney and hypertension

被引:2
作者
Quack, I. [1 ]
Rump, L. C. [1 ]
机构
[1] Univ Dusseldorf, Univ Klin, Klin Nephrol, D-40225 Dusseldorf, Germany
来源
INTERNIST | 2009年 / 50卷 / 04期
关键词
Arterial hypertension; Microalbuminuria; Chronic kidney disease; Hypertensive nephropathy; Cardiovascular risk; STAGE RENAL-DISEASE; CONVERTING-ENZYME-INHIBITOR; RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE; CARDIOVASCULAR OUTCOMES; MICROANGIOPATHIC HEMOLYSIS; SYMPATHETIC OVERACTIVITY; PROTEINURIA REDUCTION; COMBINATION TREATMENT; ALDOSTERONE SYSTEM;
D O I
10.1007/s00108-008-2290-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In patients with chronic kidney disease elevated blood pressure is a common finding, but primary hypertension can also damage healthy kidneys. Renal outcome is strictly dependent on blood pressure, no matter whether the kidneys are cause or consequence of hypertension. Furthermore, hypertension and kidney disease are strong cardiovascular risk factors. In every patient diagnosed with hypertension glomerular filtration rate has to be checked. Proteinuria and structural abnormalities of the kidneys should be ruled out. Patients with a decreased glomerular filtration rate, proteinuria or pathologic ultrasound should be seen by a nephrologist. A strict antihypertensive therapy (blood pressure < 130/80 mmHg) can substantially improve the prognosis of hypertensive renal patients. In patients with kidney damage, inhibitors of the renin-angiotensin-system are preferred. To avoid adverse events a close monitoring of antihypertensive therapy is warranted.
引用
收藏
页码:410 / +
页数:10
相关论文
共 57 条
[1]  
[Anonymous], HYP MAN HYP AD PRIM
[2]  
[Anonymous], 2000, Lancet, V355, P253, DOI 10.1016/S0140-6736(99)12323-7
[3]   Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy [J].
Atkins, RC ;
Briganti, EM ;
Lewis, JB ;
Hunsicker, LG ;
Braden, G ;
de Crespigny, PJC ;
DeFerrari, G ;
Drury, P ;
Locatelli, F ;
Wiegmann, TB ;
Lewis, EJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (02) :281-287
[4]   The benefits of renin-angiotensin blockade in hypertension are dependent on blood-pressure lowering [J].
Bidani, Anil K. ;
Griffin, Karen A. .
NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (10) :542-543
[5]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[6]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[7]  
*DTSCH HOCHDR LIG, 2008, HYP LEITL
[8]   Hydrochlorothiazide, but not Candesartan, Aggravates Insulin Resistance and Causes Visceral and Hepatic Fat Accumulation The Mechanisms for the Diabetes Preventing Effect of Candesartan (MEDICA) Study [J].
Eriksson, Jan W. ;
Jansson, Per-Anders ;
Carlberg, Bo ;
Hagg, Anders ;
Kurland, Lisa ;
Svensson, Maria K. ;
Ahlstrom, HaKan ;
Strom, Conny ;
Lonn, Lars ;
Ojbrandt, Kristina ;
Johansson, Lars ;
Lind, Lars .
HYPERTENSION, 2008, 52 (06) :1030-1037
[9]   The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension [J].
Estacio, RO ;
Jeffers, BW ;
Hiatt, WR ;
Biggerstaff, SL ;
Gifford, N ;
Schrier, RW .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (10) :645-652
[10]   Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: Addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker [J].
Furumatsu, Yoshiyuki ;
Nagasawa, Yasuyuki ;
Tomida, Kodo ;
Mikami, Satoshi ;
Kaneko, Tetsuya ;
Okada, Noriyuki ;
Tsubakihara, Yoshiharu ;
Imai, Enyu ;
Shoji, Tatsuya .
HYPERTENSION RESEARCH, 2008, 31 (01) :59-67